CausalSentinel

Protein Dossier — SPON2 (Spondin-2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Heel bone mineral density (BMD) T-score automated -0.118 0.0157 6.09e-14 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years -0.166 0.0447 2.11e-04 Wald ratio 1 cis NA
Knee osteoarthritis -0.443 0.144 0.00213 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) -0.0321 0.0105 0.0022 Wald ratio 1 cis NA
Fractured bone site(s): Other bones -0.188 0.0639 0.00328 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.0283 0.00994 0.00445 Wald ratio 1 cis NA
Weight -0.0295 0.0107 0.00579 Wald ratio 1 cis NA
Lumbar spine bone mineral density -0.116 0.0443 0.00892 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate 0.213 0.0843 0.0114 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0784 0.0324 0.0155 Wald ratio 1 cis NA
Knee and hip osteoarthritis -0.241 0.101 0.017 Wald ratio 1 cis NA
Fasting proinsulin 0.0845 0.0357 0.0179 Wald ratio 1 cis NA
…and 97 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

26 association rows across 21 traits (23 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
FSTL3/SPON2 protein level ratio 5e-301 rs6836335 1 GCST90314884 no MR -> candidate analysis
NECTIN2/SPON2 protein level ratio 1e-300 rs6836335 1 GCST90315530 no MR -> candidate analysis
B4GALT1/SPON2 protein level ratio 4e-269 rs6836335 1 GCST90313434 no MR -> candidate analysis
COL6A3/SPON2 protein level ratio 1e-266 rs6836335 1 GCST90314179 no MR -> candidate analysis
GFRA1/SPON2 protein level ratio 2e-235 rs6836335 1 GCST90314923 no MR -> candidate analysis
SPON2 protein levels 8e-232 rs6836335 2 GCST90470732 no MR -> candidate analysis
Spondin-2 levels 2e-84 rs11731643 2 GCST90427266 no MR -> candidate analysis
SPON2 protein level (protein group normalized intensity) 8e-37 rs11247975 1 GCST90570755 no MR -> candidate analysis
Estimated bone mineral density 6e-23 rs544491543 1 GCST90726625 no MR -> candidate analysis
Whole body fat free mass (UKB data field 23101) 6e-17 rs113963956 1 GCST90428120 no MR -> candidate analysis
Blood protein levels 2e-16 rs878323 1 GCST006585 no MR -> candidate analysis
Circulating SPON2 levels 8e-16 rs545410362 1 GCST90859778 no MR -> candidate analysis
…and 9 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 254 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Abnormality of the skeletal system 0.787 common-variant locus no MR -> candidate analysis
Back pain 0.561 common-variant locus no MR -> candidate analysis
atrial fibrillation 0.541 common-variant locus no MR -> candidate analysis
vertebral column disorder 0.538 common-variant locus no MR -> candidate analysis
osteoarthritis, knee 0.51 common-variant locus MR: beta=-0.443, p=0.00213 (cis)
Intervertebral disk degeneration 0.421 common-variant locus no MR -> candidate analysis
vertebral joint disorder 0.412 common-variant locus no MR -> candidate analysis
osteoarthritis, hip 0.397 common-variant locus MR: beta=-0.241, p=0.017 (cis)
musculoskeletal system disorder 0.275 common-variant locus no MR -> candidate analysis
gastroesophageal reflux disease 0.235 common-variant locus no MR -> candidate analysis
medical procedure 0.168 common-variant locus no MR -> candidate analysis
sunburn 0.113 common-variant locus no MR -> candidate analysis

Of the 12 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=3.6e-12, LOEUF=1.44 — LoF-tolerant
GWAS Catalog 68 unique SNPs / 136 rows
ClinVar 252 records; 10 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance